Evidence map›Paper›PMID 28894519›Full record

ArticleMiddle East journal of digestive diseases2017

Epidemiologic Characteristics of Patients with Inflammatory Bowel Disease in Kermanshah, Iran.

Mehdi Zobeiri, Homayoon Bashiri, Lotfollah Askari, Ali Asghar Keshavars, Ramin Tavvafzadeh, Kiomars Fatahi, Farid Najafi

Open access · diamondAbstract read
In one paragraph

Article in Middle East journal of digestive diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mehdi ZobeiriDepartment of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Homayoon BashiriDepartment of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Lotfollah AskariDepartment of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Ali Asghar KeshavarsDepartment of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Ramin TavvafzadehDepartment of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Kiomars FatahiDepartment of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Farid NajafiKermanshah Health Research Center (KHRC), Kermanshah University of Medical Sciences, Kermanshah, Iran.
Kermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND This study was done to define some epidemiological aspects of inflammatory bowel disease (IBD), and to describe its characteristics in west of Iran. METHODS In this descriptive study all patient with the diagnosis of IBD who were visited in universityaffiliated medical centers, between 2014 and 2015 were recruited. Their demographic characteristics, disease-related manifestations, complications, disease course and their chief complaints were analyzed. RESULTS Of 156 referred individuals, 153 patients had ulcerative colitis (UC) and 3 patients had Crohn's diseases (CD). The mean age of the patients at diagnosis was 35.69±12.35 (range: 17-80) years with the most common age group of 25-35 years and slight female predominance (51.9%). More urban patients were registered (90.4%) and 57% had high school or upper education. Positive family history of the disease was in 25.6% and 66.6% had four or more family members. Furthermore, 51.9% had left sided colitis and 40.4% had pancolitis with bloody diarrhea (79.5%) and abdominal pain (68.6%) as the most common manifestations. 36.5% had other autoimmune diseases. Multiple flare was seen in 47.4%, most commonly due to drug discontinuation (26.28%). Hospital admission was reported in 34.6%. History of contraceptive pill use was in 38.8% of the female patients. CONCLUSION The demographic and clinical manifestations of IBD are usually the same as other developing countries; however, the rarity of CD is eminent. Although the accurate epidemiological characteristic of IBD in Iran is still obscure, it is not a rare disease as previously thought and it seems that gradual reception of a western lifestyle may be linked to the ongoing rise in IBD.

Indexed as

EpidemiologyInflammatory bowel diseaseIranKermanshah

Identifiers

PMID28894519
PMCPMC5585909
OpenAlexW2734586971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.